Sort
51,593 grants matching “hepatitis”
The Epitranscriptome as a Novel Mechanism of Arsenic-Induced Diabetes.
$644,088Ana Navas-Acien · Columbia University Health Sciences · R01 · FY2022 · ES
Metabolic control of gut-brain axis in Familial Dysautonomia
$644,043Frances Lefcort · Montana State University - Bozeman · R01 · FY2020 · DK
MECHANISMS OF CHRONIC HEPATITIS B INFECTION
$643,993Vaccine Research Institute Of San Diego · R01 · FY2002 · AI
Neural Bases of Cephalic Phase Endocrine Responses
$643,900Alan C Spector · Florida State University · R01 · FY2019 · DK
Allosteric regulation of SIRT1 by a PACS-2 and DBC1 regulatory hub
$643,772Angela M. Gronenborn · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
RCT of a social-network oriented mhealth based intervention to increase access and adherence to HCV treatment and HIV viral suppression
$643,731Carl A Latkin · Johns Hopkins University · R01 · FY2019 · DA
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms
$643,683Robert C Kaplan · Albert Einstein College Of Medicine, Inc · R01 · FY2015 · HL
HEPATITIS C IN NEW IDUS: IMPLICATIONS FOR HIV PREVENTION
$643,589New York Academy Of Medicine · R01 · FY2001 · DA
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians
$643,552Anand Kumar Rohatgi · Ut Southwestern Medical Center · R01 · FY2024 · HL
Brief Intervention for Drug Misuse for the Emergency Department (BIDMED)
$643,508Roland C Merchant · Rhode Island Hospital · R01 · FY2010 · DA
Hepatitis C Pathogenesis & The Human Genome
$643,505David L Thomas · Johns Hopkins University · R01 · FY2008 · DA
Optimization of fibroblast-selective inhibitors of YAP/TAZ as novel therapeutics for Pulmonary Fibrosis
$643,499Susanne Heynen-Genel · Sanford Burnham Prebys Medical Discovery Institute · R61 · FY2022 · HL
Discovery of SARS-CoV-2 antivirals using a replicon assay
$643,490Stefan G Sarafianos · Emory University · R01 · FY2023 · AI
Role of Gut Associated Lymphoid Tissue in HIV Persistence
$643,468Joseph K. Wong · Northern California Institute/Res/Edu · R56 · FY2011 · AI
GENE REGULATORY NETWORKS AS TARGETS AND BIOMARKERS FOR LIVER CANCER CHEMOPREVENTION AFTER CLEARANCE OF ONCOGENIC HEPATITIS C VIRUS
$643,395Icahn School Of Medicine At Mount Sinai · · FY2016 · Department of the Army
Adipose MTP and FIT2 in the regulation of plasma lipids, obesity and atherosclerosis
$643,387M Mahmood Hussain · Nyu Long Island School Of Medicine · P01 · FY2023 · HL
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations
$643,378Keoki Williams · Henry Ford Health System · R01 · FY2018 · DK
CAREER: Establishing the mechanistic role of differential phosphorylation in regulating viral life-cycle processes
$643,259Jodi Hadden-Perilla · University Of Delaware · · FY2023 · BIO
The Transitional Liver Clinic (TLC): Reducing Liver Disease Readmission
$643,003Eric Orman · Indiana University Indianapolis · R01 · FY2025 · DK
Risk prediction methods
$642,941Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Human population based genetic studies to elucidate the biology of NAFLD
$642,907Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2019 · DK
Mechanisms Regulating Neurotensin Secretion and Function
$642,896Bernard Mark Evers · University Of Kentucky · R01 · FY2024 · DK
Bio-Psycho-Social Drivers of Disparities in Liver Disease Progression among Korean Americans with Hepatitis B Infection
$642,723Hee-Soon Juon · Thomas Jefferson University · R01 · FY2022 · DK
Mechanisms of HBV Functional Cure During Tenofovir-based ART in HIV/HBV Coinfection
$642,704Michael Jeffrey Vinikoor · University Of Alabama At Birmingham · R01 · FY2022 · AI
Small molecule targeting viral nucleotidyltransferases
$642,702Stuart F. J. Le Grice · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA